Location: UK Other
Salary: £38,866-£48,714 in accordance with the EU Marie Sklodowska-Curie financial guidelines for this scheme
Closing Date: 31/12/2019
Building on the success of ONCORNET (Oncogenic GPCR Network of Excellence and Training) ITN, its second iteration, ONCORNET2.0, is recruiting two Early Stage Researchers (ESRs) to become part of this exciting consortium.
ONCORNET2.0 will bring together the leading GPCR research groups in Europe and 15 Early Stage Researchers and offers generously funded positions on high profile research projects with excellent facilities for research and training in both academic and industrial settings. Successful applicants will also register for a funded PhD at the University of Nottingham.
We are seeking highly motivated and enthusiastic ESRs to investigate the signalling and spatial organisation of chemokine receptors using advanced imaging techniques in combination with classical biochemistry, pharmacology and cell biology approaches.
Candidates should have a MSc degree in Biochemistry, Pharmacology or related Biomedical degrees. A strong background in cell biology, signal transduction and GPCR molecular and cellular pharmacology is strongly preferred. Candidates may be of any nationality but must not, at the time of recruitment, have resided or carried out their main activity (work, studies, etc) in the UK for more than 12 months in the 3 last years immediately prior to starting their contract of employment.
To apply please use the following link
Our University has always been a supportive, inclusive, caring and positive community. We warmly welcome those of different cultures, ethnicities and beliefs – indeed this very diversity is vital to our success, it is fundamental to our values and enriches life on campus. We welcome applications from UK, Europe and from across the globe. For more information on the support we offer our international colleagues, click here.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 859957